Chiesi blocks Japanese drugmaker’s new brand at EU General Court
01-07-2020
EU adopts SPC manufacturing waiver
16-05-2019
Quinta / Shutterstock.com
The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
European Commission, generics, competition, Pharmaceutical Strategy for Europe, accessible, affordable, Ursula von der Leyen, Stella Kyriakides
